ESCITSLOPRAM

ESCITSLOPRAM was reported 59042 times

ESCITSLOPRAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL LUNG CAPACITY ABNORMAL 106 0.2725
1 SPIROMETRY ABNORMAL 140 0.2341
2 PULMONARY VASCULITIS 125 0.2323
3 CAPILLARITIS 59 0.2138
4 MITE ALLERGY 129 0.1969
5 GENITAL ANAESTHESIA 49 0.1822
6 STEROID DEPENDENCE 141 0.1606
7 AMAUROSIS FUGAX 168 0.1560
8 MYCOTIC ALLERGY 127 0.1485
9 CATARRH 134 0.1482
10 DUST ALLERGY 127 0.1295
11 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 52 0.1294
12 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 85 0.1160
13 CONJUNCTIVITIS ALLERGIC 146 0.0985
14 AUTOSCOPY 46 0.0852
15 BURNS SECOND DEGREE 139 0.0792
16 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 152 0.0769
17 NEURITIS 117 0.0757
18 RESTING TREMOR 40 0.0619
19 SEROTONIN SYNDROME 1187 0.0617
20 INTRUSIVE THOUGHTS 67 0.0569
21 OROMANDIBULAR DYSTONIA 41 0.0562
22 PSEUDOMONAL BACTERAEMIA 48 0.0562
23 GENITAL HYPOAESTHESIA 57 0.0558
24 PHYSICAL DECONDITIONING 143 0.0555
25 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 112 0.0549
26 RESPIRATORY DISORDER NEONATAL 85 0.0524
27 NORMOCHROMIC NORMOCYTIC ANAEMIA 140 0.0466
28 RESPIRATORY SYMPTOM 132 0.0464
29 AGITATION NEONATAL 43 0.0448
30 SUSPECTED SUICIDE 210 0.0448
31 CLONUS 122 0.0445
32 SLEEP TERROR 182 0.0432
33 HYPOPNOEA 149 0.0429
34 SMALL FOR DATES BABY 212 0.0427
35 SLEEP TALKING 67 0.0394
36 HYPERREFLEXIA 137 0.0393
37 REDUCED FACIAL EXPRESSION 39 0.0384
38 FORCED EXPIRATORY VOLUME DECREASED 108 0.0381
39 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 195 0.0380
40 ALCOHOL POISONING 101 0.0377
41 EMOTIONAL POVERTY 66 0.0376
42 ANORGASMIA 97 0.0357
43 LONG QT SYNDROME 83 0.0346
44 MAJOR DEPRESSION 252 0.0344
45 DEPRESSIVE SYMPTOM 120 0.0340
46 MICROCEPHALY 43 0.0335
47 URINARY TRACT DISORDER 146 0.0324
48 PSYCHOMOTOR RETARDATION 91 0.0323
49 ELECTRIC SHOCK SENSATION 90 0.0321
50 ANTICHOLINERGIC SYNDROME 49 0.0307
51 DEREALISATION 64 0.0297
52 SEXUAL DYSFUNCTION 345 0.0294
53 BLOOD PRESSURE DIASTOLIC ABNORMAL 73 0.0287
54 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 287 0.0279
55 HAEMORRHAGIC STROKE 218 0.0279
56 TORSADE DE POINTES 214 0.0273
57 ELECTROCARDIOGRAM QT PROLONGED 970 0.0269
58 VIOLENCE-RELATED SYMPTOM 41 0.0265
59 LOSS OF LIBIDO 238 0.0264
60 PERSECUTORY DELUSION 65 0.0260
61 COLITIS MICROSCOPIC 123 0.0259
62 HYPOMANIA 94 0.0255
63 HYPERPARATHYROIDISM SECONDARY 63 0.0251
64 NEUROLOGICAL SYMPTOM 142 0.0248
65 SEDATION COMPLICATION 63 0.0247
66 LIMB DEFORMITY 39 0.0245
67 BRONCHIECTASIS 165 0.0245
68 TORTICOLLIS 51 0.0240
69 SOPOR 316 0.0238
70 POISONING DELIBERATE 226 0.0238
71 REBOUND ACID HYPERSECRETION 72 0.0238
72 NEPHROGENIC ANAEMIA 109 0.0235
73 PULMONARY ALVEOLAR HAEMORRHAGE 131 0.0233
74 HUMAN HERPESVIRUS 6 INFECTION 43 0.0227
75 BRADYKINESIA 133 0.0225
76 TALIPES 69 0.0222
77 YAWNING 59 0.0221
78 SUICIDE ATTEMPT 1338 0.0220
79 COMPLETED SUICIDE 1834 0.0220
80 HYPERTONIA 126 0.0220
81 INTENTIONAL OVERDOSE 1388 0.0216
82 PAROSMIA 160 0.0212
83 GINGIVAL PAIN 168 0.0211
84 TEMPERATURE REGULATION DISORDER 47 0.0211
85 BLOOD PRESSURE SYSTOLIC ABNORMAL 52 0.0210
86 RHINITIS 169 0.0209
87 ANXIETY DISORDER 69 0.0206
88 CEREBRAL HAEMATOMA 69 0.0205
89 CATATONIA 107 0.0204
90 MUSCLE RIGIDITY 243 0.0203
91 INTENTIONAL SELF-INJURY 408 0.0202
92 ATRIAL SEPTAL DEFECT 165 0.0197
93 ARTERIOSCLEROSIS CORONARY ARTERY 130 0.0196
94 MULTIPLE DRUG OVERDOSE INTENTIONAL 63 0.0196
95 METHAEMOGLOBINAEMIA 45 0.0194
96 MYDRIASIS 243 0.0189
97 AKATHISIA 257 0.0188
98 IMPAIRED QUALITY OF LIFE 269 0.0187
99 CARDIAC MURMUR 157 0.0181
100 COMA SCALE ABNORMAL 52 0.0179
101 BEHAVIOUR DISORDER 97 0.0179
102 FULL BLOOD COUNT ABNORMAL 186 0.0176
103 IMPULSIVE BEHAVIOUR 65 0.0173
104 POTENTIATING DRUG INTERACTION 58 0.0173
105 OCULAR DISCOMFORT 193 0.0172
106 MANIA 281 0.0171
107 BUNDLE BRANCH BLOCK LEFT 72 0.0170
108 HYPERTHERMIA 128 0.0167
109 FEELING OF DESPAIR 78 0.0167
110 NEUROLEPTIC MALIGNANT SYNDROME 197 0.0166
111 GESTATIONAL DIABETES 79 0.0166
112 GENERALISED OEDEMA 205 0.0165
113 DRUG INTERACTION 2613 0.0165
114 MYOCLONUS 196 0.0164
115 ARTERIOSCLEROSIS 152 0.0161
116 STOMA SITE DISCHARGE 44 0.0161
117 DELUSION 249 0.0160
118 POLYDIPSIA 63 0.0159
119 PARKINSONISM 155 0.0159
120 ANGLE CLOSURE GLAUCOMA 40 0.0157
121 ALTERED STATE OF CONSCIOUSNESS 339 0.0156
122 BRUXISM 84 0.0156
123 EXPOSURE VIA BREAST MILK 61 0.0153
124 HALLUCINATIONS, MIXED 64 0.0152
125 HYPONATRAEMIA 855 0.0152
126 COMA 721 0.0151
127 SINUS BRADYCARDIA 146 0.0151
128 VENTRICULAR SEPTAL DEFECT 86 0.0150
129 OBSTRUCTIVE AIRWAYS DISORDER 167 0.0150
130 ALCOHOL ABUSE 40 0.0149
131 SUICIDAL IDEATION 1353 0.0148
132 RED CELL DISTRIBUTION WIDTH INCREASED 61 0.0147
133 HEAD DISCOMFORT 258 0.0146
134 ANTIPSYCHOTIC DRUG LEVEL INCREASED 41 0.0145
135 BRADYPHRENIA 95 0.0145
136 TACHYPHRENIA 50 0.0144
137 SUICIDAL BEHAVIOUR 60 0.0144
138 STUPOR 46 0.0143
139 FIBROSIS 44 0.0143
140 ALCOHOLISM 61 0.0142
141 VASCULITIS 165 0.0141
142 HALLUCINATION, AUDITORY 221 0.0139
143 ORTHOSTATIC HYPOTENSION 242 0.0139
144 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 236 0.0139
145 AFFECTIVE DISORDER 109 0.0139
146 GALACTORRHOEA 89 0.0138
147 AUTONOMIC NERVOUS SYSTEM IMBALANCE 40 0.0137
148 CARDIOGENIC SHOCK 196 0.0136
149 NEGATIVE THOUGHTS 40 0.0136
150 HALLUCINATION, VISUAL 288 0.0136
151 SELF-INJURIOUS IDEATION 56 0.0133
152 BUNDLE BRANCH BLOCK RIGHT 61 0.0133
153 MICTURITION DISORDER 46 0.0133
154 HYPERACUSIS 49 0.0132
155 HAEMATEMESIS 332 0.0131
156 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 627 0.0130
157 NODULE 170 0.0130
158 APATHY 190 0.0130
159 FREEZING PHENOMENON 47 0.0127
160 HYPERNATRAEMIA 63 0.0126
161 HYPOTONIA 126 0.0126
162 ON AND OFF PHENOMENON 70 0.0126
163 SINUS TACHYCARDIA 179 0.0126
164 TRISMUS 65 0.0126
165 TUBULOINTERSTITIAL NEPHRITIS 235 0.0125
166 PANIC DISORDER 48 0.0124
167 TENSION 75 0.0123
168 SWOLLEN TONGUE 383 0.0123
169 HAEMODYNAMIC INSTABILITY 93 0.0122
170 CARDIO-RESPIRATORY ARREST 510 0.0122
171 FOETAL EXPOSURE DURING PREGNANCY 987 0.0121
172 HOMICIDAL IDEATION 49 0.0121
173 TOXIC ENCEPHALOPATHY 61 0.0120
174 HYPERPHAGIA 48 0.0120
175 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 106 0.0120
176 RESTLESSNESS 431 0.0118
177 PULSELESS ELECTRICAL ACTIVITY 49 0.0117
178 PRESYNCOPE 284 0.0117
179 IMPAIRED WORK ABILITY 249 0.0116
180 SEDATION 305 0.0116
181 LOGORRHOEA 41 0.0116
182 IMPAIRED GASTRIC EMPTYING 156 0.0114
183 AGITATION 840 0.0114
184 PANIC ATTACK 415 0.0114
185 SNORING 43 0.0114
186 TINNITUS 522 0.0114
187 WITHDRAWAL SYNDROME 477 0.0113
188 FOETAL GROWTH RESTRICTION 69 0.0113
189 PSYCHIATRIC SYMPTOM 83 0.0112
190 ANAL INCONTINENCE 101 0.0112
191 ERECTILE DYSFUNCTION 288 0.0112
192 POISONING 140 0.0111
193 GENERALISED TONIC-CLONIC SEIZURE 184 0.0111
194 NIGHTMARE 384 0.0111
195 PARANOIA 191 0.0111
196 MUSCLE TWITCHING 253 0.0110
197 TONSILLITIS 57 0.0109
198 HYPOMAGNESAEMIA 152 0.0109
199 PRODUCT SUBSTITUTION ISSUE 625 0.0108
200 METABOLIC ACIDOSIS 344 0.0107
201 DEPRESSED MOOD 568 0.0107
202 DRUG WITHDRAWAL SYNDROME NEONATAL 157 0.0106
203 FAECALOMA 58 0.0106
204 DEPRESSED LEVEL OF CONSCIOUSNESS 416 0.0105
205 ENURESIS 42 0.0104
206 BLOOD PROLACTIN INCREASED 49 0.0104
207 END STAGE RENAL DISEASE 189 0.0104
208 OBSESSIVE-COMPULSIVE DISORDER 83 0.0103
209 ELECTROCARDIOGRAM ABNORMAL 81 0.0103
210 ANHEDONIA 271 0.0103
211 PSYCHOMOTOR HYPERACTIVITY 171 0.0103
212 TOXICITY TO VARIOUS AGENTS 1737 0.0103
213 SOCIAL AVOIDANT BEHAVIOUR 59 0.0102
214 DYSKINESIA 414 0.0102
215 POST-TRAUMATIC STRESS DISORDER 68 0.0101
216 TACHYCARDIA 900 0.0101
217 VITAMIN B12 DEFICIENCY 41 0.0101
218 SOMNAMBULISM 66 0.0100
219 MIOSIS 80 0.0100
220 SOMNOLENCE 1997 0.0099
221 VENTRICULAR FIBRILLATION 109 0.0098
222 FREQUENT BOWEL MOVEMENTS 265 0.0098
223 NYSTAGMUS 52 0.0098
224 DEPRESSION 2224 0.0098
225 DECREASED INTEREST 57 0.0097
226 MATERNAL DRUGS AFFECTING FOETUS 74 0.0096
227 DIPLOPIA 250 0.0096
228 IRON DEFICIENCY 43 0.0096
229 PRODUCT ADMINISTRATION INTERRUPTED 75 0.0095
230 COGNITIVE DISORDER 445 0.0095
231 DISTURBANCE IN ATTENTION 512 0.0095
232 DRUG LEVEL INCREASED 155 0.0094
233 PANIC REACTION 67 0.0093
234 HALLUCINATION 698 0.0093
235 DELIRIUM 321 0.0092
236 ATRIOVENTRICULAR BLOCK FIRST DEGREE 40 0.0092
237 CHRONIC KIDNEY DISEASE 699 0.0092
238 MENTAL DISORDER 400 0.0092
239 PSYCHOTIC DISORDER 269 0.0091
240 PHOTOPHOBIA 169 0.0090
241 BRAIN INJURY 90 0.0090
242 ATRIOVENTRICULAR BLOCK COMPLETE 60 0.0090
243 OVERWEIGHT 48 0.0089
244 SALIVARY HYPERSECRETION 88 0.0088
245 ANXIETY 2500 0.0088
246 RESTLESS LEGS SYNDROME 159 0.0087
247 HYPOKALAEMIA 403 0.0087
248 CONFUSIONAL STATE 1407 0.0087
249 SLEEP DISORDER 613 0.0087
250 DYSGRAPHIA 57 0.0086
251 INITIAL INSOMNIA 88 0.0086
252 ASCITES 251 0.0085
253 BRADYCARDIA 452 0.0085
254 HYPOKINESIA 123 0.0085
255 TREMOR 1403 0.0084
256 GAMMA-GLUTAMYLTRANSFERASE INCREASED 185 0.0083
257 MYOPATHY 72 0.0083
258 HYPERPROLACTINAEMIA 54 0.0083
259 PULSE ABSENT 39 0.0082
260 MENTAL IMPAIRMENT 198 0.0082
261 RHABDOMYOLYSIS 337 0.0081
262 PRE-EXISTING CONDITION IMPROVED 50 0.0080
263 BIPOLAR DISORDER 87 0.0080
264 URINARY INCONTINENCE 237 0.0080
265 PULMONARY FIBROSIS 153 0.0080
266 MYOCARDITIS 91 0.0079
267 ACCIDENTAL OVERDOSE 290 0.0079
268 DYSPHORIA 40 0.0079
269 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 48 0.0079
270 URINARY RETENTION 263 0.0079
271 STATUS EPILEPTICUS 89 0.0079
272 HYPOVOLAEMIA 46 0.0079
273 ACUTE KIDNEY INJURY 1199 0.0078
274 MEDICATION ERROR 433 0.0078
275 BRAIN FOG 122 0.0078
276 ATRIOVENTRICULAR BLOCK 60 0.0078
277 ERYSIPELAS 39 0.0078
278 HEPATOCELLULAR INJURY 110 0.0078
279 UNRESPONSIVE TO STIMULI 199 0.0077
280 POLYURIA 63 0.0077
281 DRUG ABUSE 640 0.0077
282 HAEMATOMA 199 0.0077
283 HEPATITIS CHOLESTATIC 46 0.0076
284 DISORIENTATION 302 0.0076
285 FORMICATION 53 0.0076
286 CRYING 276 0.0076
287 AGGRESSION 379 0.0076
288 THINKING ABNORMAL 141 0.0076
289 CHOLESTASIS 145 0.0075
290 NORMAL NEWBORN 41 0.0075
291 POOR QUALITY SLEEP 162 0.0075
292 FALL 2498 0.0075
293 ATAXIA 89 0.0075
294 MUSCLE SPASTICITY 92 0.0075
295 HYPERSOMNIA 212 0.0074
296 HAEMOPTYSIS 206 0.0074
297 TROPONIN INCREASED 56 0.0074
298 HYPOXIA 259 0.0073
299 SUBDURAL HAEMATOMA 105 0.0073
300 VERTIGO 446 0.0073
301 ECCHYMOSIS 50 0.0073
302 WALKING AID USER 48 0.0073
303 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 187 0.0073
304 DRUG USE DISORDER 61 0.0072
305 COORDINATION ABNORMAL 101 0.0072
306 DECREASED ACTIVITY 78 0.0072
307 APHTHOUS ULCER 56 0.0072
308 BODY TEMPERATURE DECREASED 71 0.0072
309 HAEMATURIA 246 0.0072
310 RESPIRATORY DEPRESSION 88 0.0072
311 VITAMIN D DEFICIENCY 70 0.0072
312 HYPERTRIGLYCERIDAEMIA 42 0.0072
313 BLOOD PRESSURE FLUCTUATION 172 0.0072
314 RECTAL HAEMORRHAGE 307 0.0071
315 BLOOD PRESSURE SYSTOLIC INCREASED 139 0.0071
316 EUPHORIC MOOD 73 0.0071
317 JOINT EFFUSION 49 0.0071
318 APPETITE DISORDER 47 0.0071
319 HAEMATOCHEZIA 390 0.0071
320 DISSOCIATION 54 0.0070
321 THERAPY CHANGE 69 0.0070
322 RESPIRATORY ARREST 193 0.0070
323 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 498 0.0070
324 ASPHYXIA 57 0.0070
325 EXTRAPYRAMIDAL DISORDER 173 0.0070
326 SYNCOPE 696 0.0069
327 UPPER GASTROINTESTINAL HAEMORRHAGE 117 0.0069
328 CONDITION AGGRAVATED 2110 0.0069
329 VENTRICULAR EXTRASYSTOLES 72 0.0069
330 HYPOCALCAEMIA 131 0.0069
331 PRODUCTIVE COUGH 330 0.0069
332 INCREASED APPETITE 132 0.0069
333 BALANCE DISORDER 594 0.0069
334 EPILEPSY 210 0.0069
335 COLITIS ULCERATIVE 307 0.0069
336 HEAD INJURY 217 0.0069
337 NERVE COMPRESSION 63 0.0068
338 FEELING JITTERY 130 0.0068
339 LIPASE INCREASED 52 0.0068
340 CEREBRAL DISORDER 50 0.0068
341 RIB FRACTURE 139 0.0068
342 STRESS CARDIOMYOPATHY 39 0.0067
343 IRRITABILITY 403 0.0067
344 HYPOTHYROIDISM 214 0.0067
345 INCOHERENT 43 0.0066
346 CARDIAC ARREST 548 0.0066
347 INCONTINENCE 70 0.0066
348 SEIZURE 764 0.0066
349 SHOCK 152 0.0066
350 SLEEP APNOEA SYNDROME 126 0.0066
351 DIZZINESS POSTURAL 64 0.0066
352 HYPERHIDROSIS 850 0.0066
353 LEFT VENTRICULAR DYSFUNCTION 44 0.0066
354 BLINDNESS 266 0.0065
355 SUBSTANCE ABUSE 53 0.0065
356 LYMPHOEDEMA 45 0.0065
357 VENTRICULAR TACHYCARDIA 107 0.0065
358 HYPERAESTHESIA 53 0.0064
359 NEUTROPHIL COUNT INCREASED 66 0.0064
360 DYSTONIA 125 0.0064
361 TOOTH FRACTURE 71 0.0064
362 GRAND MAL CONVULSION 59 0.0064
363 MOTOR DYSFUNCTION 65 0.0064
364 PULMONARY EMBOLISM 606 0.0064
365 ANGER 215 0.0064
366 DEMENTIA 177 0.0063
367 APHASIA 191 0.0063
368 COELIAC DISEASE 62 0.0063
369 BLOOD IRON DECREASED 75 0.0063
370 INSOMNIA 1683 0.0063
371 CLOSTRIDIUM DIFFICILE COLITIS 67 0.0063
372 BLOOD CALCIUM DECREASED 71 0.0063
373 ABNORMAL DREAMS 174 0.0063
374 RESPIRATORY TRACT INFECTION 164 0.0063
375 ELECTROLYTE IMBALANCE 73 0.0063
376 ANURIA 54 0.0063
377 HYPOTENSION 1252 0.0062
378 ENCEPHALOPATHY 153 0.0062
379 ABNORMAL BEHAVIOUR 245 0.0062
380 BLOOD ALBUMIN DECREASED 49 0.0062
381 PRODUCT PRESCRIBING ERROR 147 0.0062
382 PSYCHOLOGICAL TRAUMA 53 0.0061
383 MICTURITION URGENCY 70 0.0061
384 SCREAMING 39 0.0061
385 HEPATIC CYTOLYSIS 78 0.0061
386 POLYP 40 0.0061
387 CAESAREAN SECTION 71 0.0061
388 PRESCRIBED OVERDOSE 118 0.0061
389 BEDRIDDEN 80 0.0061
390 BLOOD CREATINE PHOSPHOKINASE INCREASED 175 0.0061
391 FRUSTRATION TOLERANCE DECREASED 49 0.0061
392 LYMPHOCYTE COUNT DECREASED 107 0.0060
393 LETHARGY 347 0.0060
394 WEIGHT FLUCTUATION 63 0.0060
395 MENTAL STATUS CHANGES 167 0.0060
396 DEEP VEIN THROMBOSIS 390 0.0060
397 PEMPHIGOID 45 0.0060
398 HIATUS HERNIA 77 0.0059
399 ANGIOEDEMA 263 0.0059
400 WHEEZING 349 0.0059
401 BLOOD ALKALINE PHOSPHATASE INCREASED 146 0.0059
402 ACUTE RESPIRATORY FAILURE 113 0.0059
403 MUSCLE TIGHTNESS 95 0.0059
404 SENSORY LOSS 47 0.0058
405 HYPOGLYCAEMIA 283 0.0058
406 INTENTIONAL PRODUCT USE ISSUE 511 0.0058
407 DROOLING 40 0.0058
408 PREMATURE BABY 174 0.0058
409 TREATMENT NONCOMPLIANCE 315 0.0058
410 AGRANULOCYTOSIS 107 0.0058
411 BLADDER DISORDER 57 0.0057
412 QUALITY OF LIFE DECREASED 77 0.0057
413 BODY TEMPERATURE INCREASED 117 0.0057
414 ARRHYTHMIA 271 0.0057
415 PALPITATIONS 670 0.0057
416 AFFECT LABILITY 55 0.0057
417 BLOOD PRESSURE DIASTOLIC DECREASED 42 0.0057
418 C-REACTIVE PROTEIN INCREASED 207 0.0057
419 WRIST FRACTURE 68 0.0057
420 TRICUSPID VALVE INCOMPETENCE 45 0.0057
421 FLANK PAIN 53 0.0056
422 IRON DEFICIENCY ANAEMIA 52 0.0056
423 BLOOD POTASSIUM DECREASED 169 0.0056
424 VITAMIN D DECREASED 48 0.0056
425 FEAR 150 0.0056
426 DEFAECATION URGENCY 39 0.0056
427 GAIT INABILITY 186 0.0056
428 PNEUMONIA ASPIRATION 139 0.0056
429 DYSARTHRIA 209 0.0055
430 APNOEA 43 0.0055
431 CIRCULATORY COLLAPSE 94 0.0055
432 RED BLOOD CELL SEDIMENTATION RATE INCREASED 61 0.0055
433 EYE PAIN 311 0.0055
434 LOSS OF CONSCIOUSNESS 705 0.0055
435 SUBARACHNOID HAEMORRHAGE 56 0.0055
436 ABNORMAL FAECES 45 0.0055
437 DYSPHONIA 321 0.0055
438 OXYGEN SATURATION DECREASED 308 0.0055
439 MITRAL VALVE INCOMPETENCE 62 0.0055
440 SPINAL OSTEOARTHRITIS 48 0.0055
441 GENERAL PHYSICAL HEALTH DETERIORATION 632 0.0055
442 INTERVERTEBRAL DISC PROTRUSION 119 0.0054
443 HYPOTHERMIA 55 0.0054
444 THIRST 97 0.0054
445 PHARYNGEAL SWELLING 53 0.0054
446 MIDDLE INSOMNIA 101 0.0054
447 RESPIRATORY RATE INCREASED 48 0.0054
448 DERMATITIS ALLERGIC 68 0.0054
449 MOOD ALTERED 147 0.0054
450 LIVE BIRTH 45 0.0054
451 FAECES SOFT 39 0.0054
452 MUSCULOSKELETAL STIFFNESS 468 0.0053
453 SKIN LACERATION 58 0.0053
454 COVID-19 928 0.0053
455 MIGRAINE 504 0.0053
456 ATELECTASIS 51 0.0053
457 PERSONALITY CHANGE 49 0.0053
458 ADRENAL INSUFFICIENCY 64 0.0053
459 MOOD SWINGS 168 0.0053
460 TOXIC EPIDERMAL NECROLYSIS 80 0.0053
461 HOSPICE CARE 52 0.0053
462 LEUKOCYTOSIS 95 0.0052
463 PRODUCT ADMINISTRATION ERROR 106 0.0052
464 HAEMATOCRIT DECREASED 104 0.0052
465 THERAPY NON-RESPONDER 235 0.0052
466 HEAVY MENSTRUAL BLEEDING 47 0.0052
467 MEMORY IMPAIRMENT 717 0.0052
468 RENAL INJURY 155 0.0052
469 BLOOD PRESSURE INCREASED 797 0.0052
470 DYSSTASIA 152 0.0052
471 INTERVERTEBRAL DISC DEGENERATION 48 0.0052
472 TRANSAMINASES INCREASED 115 0.0052
473 LUNG DISORDER 253 0.0052
474 LIGAMENT SPRAIN 51 0.0052
475 CARDIOTOXICITY 46 0.0052
476 ISCHAEMIC STROKE 92 0.0051
477 HEPATIC STEATOSIS 96 0.0051
478 SPEECH DISORDER 270 0.0051
479 DISEASE RECURRENCE 245 0.0051
480 EMOTIONAL DISORDER 158 0.0051
481 ABDOMINAL PAIN 1186 0.0051
482 HYPERKALAEMIA 178 0.0051
483 PANCREATITIS ACUTE 114 0.0051
484 EAR DISCOMFORT 52 0.0051
485 THERAPY PARTIAL RESPONDER 79 0.0051
486 DEHYDRATION 675 0.0051
487 POLLAKIURIA 211 0.0051
488 SYSTEMIC LUPUS ERYTHEMATOSUS 178 0.0050
489 ECONOMIC PROBLEM 76 0.0050
490 AMNESIA 326 0.0050
491 DRUG LEVEL DECREASED 51 0.0050
492 DECREASED APPETITE 1162 0.0050
493 GASTROINTESTINAL PAIN 55 0.0050
494 LACTIC ACIDOSIS 161 0.0050
495 BREAST PAIN 53 0.0050
496 FEELING COLD 138 0.0050
497 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 272 0.0050
498 SPUTUM DISCOLOURED 47 0.0050
499 HUNGER 69 0.0049
500 ECZEMA 259 0.0049
501 DYSURIA 182 0.0049
502 NOCTURIA 60 0.0049
503 OVERDOSE 1066 0.0049
504 SCHIZOPHRENIA 60 0.0049
505 CHILLS 578 0.0049
506 FACIAL PAIN 44 0.0049
507 PRESCRIBED UNDERDOSE 98 0.0049
508 DECUBITUS ULCER 40 0.0049
509 EOSINOPHILIA 86 0.0049
510 HEART RATE DECREASED 172 0.0049
511 OBESITY 78 0.0049
512 RENAL TUBULAR NECROSIS 48 0.0049
513 CEREBRAL HAEMORRHAGE 175 0.0049
514 DRUG INTOLERANCE 472 0.0049
515 DIZZINESS 2436 0.0049
516 BLOOD SODIUM DECREASED 92 0.0049
517 SEASONAL ALLERGY 69 0.0049
518 SWELLING FACE 317 0.0049
519 ASTHENIA 1829 0.0049
520 ANKYLOSING SPONDYLITIS 64 0.0049
521 PYELONEPHRITIS 42 0.0048
522 ABSCESS 77 0.0048
523 HYPOPHAGIA 123 0.0048
524 OSTEOPENIA 73 0.0048
525 LYMPHOPENIA 68 0.0048
526 INTERNATIONAL NORMALISED RATIO INCREASED 137 0.0048
527 SMALL INTESTINAL OBSTRUCTION 59 0.0048
528 ABDOMINAL DISCOMFORT 803 0.0048
529 WEIGHT INCREASED 1072 0.0048
530 TACHYPNOEA 65 0.0048
531 TOXIC SKIN ERUPTION 48 0.0048
532 HYPERTENSIVE CRISIS 53 0.0048
533 POOR VENOUS ACCESS 49 0.0047
534 THERAPY CESSATION 243 0.0047
535 DRY MOUTH 383 0.0047
536 AUTOIMMUNE DISORDER 46 0.0047
537 NIGHT SWEATS 152 0.0047
538 ARTHRITIS 371 0.0047
539 URINARY TRACT INFECTION 804 0.0047
540 FEEDING DISORDER 95 0.0047
541 GASTRIC ULCER 89 0.0047
542 ALANINE AMINOTRANSFERASE INCREASED 287 0.0047
543 MOVEMENT DISORDER 150 0.0047
544 GAIT DISTURBANCE 892 0.0047
545 MALNUTRITION 52 0.0046
546 RETCHING 99 0.0046
547 BLOOD BILIRUBIN INCREASED 125 0.0046
548 FATIGUE 3602 0.0046
549 SENSORY DISTURBANCE 74 0.0046
550 PLATELET COUNT INCREASED 60 0.0046
551 SUPRAVENTRICULAR TACHYCARDIA 44 0.0046
552 ASTHMA 517 0.0046
553 HIP FRACTURE 147 0.0046
554 WEIGHT DECREASED 1273 0.0046
555 GLOMERULAR FILTRATION RATE DECREASED 56 0.0046
556 DISCOMFORT 278 0.0046
557 PRODUCT DOSE OMISSION IN ERROR 129 0.0046
558 VOMITING 2140 0.0045
559 MOBILITY DECREASED 327 0.0045
560 MELAENA 100 0.0045
561 CLOSTRIDIUM DIFFICILE INFECTION 99 0.0045
562 OSTEOARTHRITIS 192 0.0045
563 INTENTIONAL DOSE OMISSION 129 0.0045
564 DIARRHOEA 2920 0.0045
565 SPINAL PAIN 53 0.0045
566 RED BLOOD CELL COUNT DECREASED 129 0.0045
567 SLUGGISHNESS 46 0.0045
568 TARDIVE DYSKINESIA 127 0.0045
569 PREGNANCY 90 0.0045
570 CYSTITIS 143 0.0045
571 RENAL FAILURE 594 0.0045
572 NECK PAIN 250 0.0045
573 PRODUCT USE IN UNAPPROVED INDICATION 1106 0.0045
574 MUSCULAR WEAKNESS 507 0.0045
575 MUSCULOSKELETAL CHEST PAIN 69 0.0045
576 HOT FLUSH 335 0.0044
577 CONSTIPATION 969 0.0044
578 DYSPNOEA EXERTIONAL 167 0.0044
579 NERVOUSNESS 230 0.0044
580 DIARRHOEA HAEMORRHAGIC 41 0.0044
581 ASPIRATION 48 0.0044
582 THROMBOSIS 352 0.0044
583 HEADACHE 2737 0.0044
584 BRAIN OEDEMA 55 0.0043
585 DRUG TOXICITY 59 0.0043
586 FACE OEDEMA 73 0.0043
587 WHITE BLOOD CELL COUNT INCREASED 166 0.0043
588 NAUSEA 3424 0.0043
589 HEART RATE INCREASED 428 0.0043
590 NEURALGIA 105 0.0043
591 SKIN HAEMORRHAGE 64 0.0043
592 NERVE INJURY 48 0.0043
593 MYALGIA 732 0.0043
594 HERNIA 83 0.0043
595 DYSGEUSIA 318 0.0043
596 BLOOD POTASSIUM INCREASED 69 0.0042
597 DYSPHAGIA 403 0.0042
598 SEPSIS 473 0.0042
599 BRONCHITIS 312 0.0042
600 CARPAL TUNNEL SYNDROME 59 0.0042
601 ABDOMINAL PAIN UPPER 867 0.0042
602 PARAESTHESIA 659 0.0042
603 EATING DISORDER 89 0.0042
604 DRUG-INDUCED LIVER INJURY 131 0.0042
605 SECRETION DISCHARGE 52 0.0041
606 DIVERTICULITIS 115 0.0041
607 TOOTHACHE 75 0.0041
608 RESPIRATORY DISTRESS 114 0.0041
609 BURSITIS 50 0.0041
610 FIBROMYALGIA 100 0.0041
611 FEELING ABNORMAL 984 0.0041
612 PRODUCT DOSE OMISSION 268 0.0041
613 ASPARTATE AMINOTRANSFERASE INCREASED 218 0.0041
614 ORAL HERPES 80 0.0041
615 VISION BLURRED 562 0.0041
616 DECREASED IMMUNE RESPONSIVENESS 40 0.0041
617 EXPOSURE DURING PREGNANCY 253 0.0041
618 SUDDEN DEATH 43 0.0041
619 FOOT FRACTURE 77 0.0041
620 CONTUSION 389 0.0040
621 MALAISE 1769 0.0040
622 GINGIVAL BLEEDING 55 0.0040
623 GASTROOESOPHAGEAL REFLUX DISEASE 324 0.0040
624 TOOTH INFECTION 53 0.0040
625 SARS-COV-2 TEST POSITIVE 53 0.0040
626 FISTULA 45 0.0040
627 JAUNDICE 107 0.0040
628 COLD SWEAT 70 0.0040
629 MYOCARDIAL ISCHAEMIA 45 0.0040
630 PRODUCT AVAILABILITY ISSUE 90 0.0039
631 GASTRITIS 104 0.0039
632 GASTROINTESTINAL DISORDER 354 0.0039
633 MUSCULOSKELETAL DISCOMFORT 68 0.0039
634 LIVER INJURY 96 0.0039
635 THERAPY INTERRUPTED 279 0.0039
636 TREATMENT FAILURE 323 0.0039
637 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 702 0.0039
638 PREMATURE DELIVERY 62 0.0039
639 MOUTH ULCERATION 82 0.0039
640 BLOOD PRESSURE DECREASED 258 0.0039
641 IMPAIRED DRIVING ABILITY 44 0.0039
642 PAIN IN EXTREMITY 1139 0.0039
643 UPPER LIMB FRACTURE 77 0.0039
644 MATERNAL EXPOSURE DURING PREGNANCY 344 0.0039
645 PALLOR 105 0.0039
646 ANAEMIA 734 0.0038
647 PANCYTOPENIA 215 0.0038
648 GLAUCOMA 74 0.0038
649 ADVERSE DRUG REACTION 345 0.0038
650 INFLUENZA 426 0.0038
651 LIMB DISCOMFORT 118 0.0038
652 HAEMORRHAGE INTRACRANIAL 57 0.0038
653 LEUKOPENIA 190 0.0038
654 PHARYNGITIS 47 0.0038
655 CENTRAL NERVOUS SYSTEM LESION 52 0.0038
656 HYPOAESTHESIA 566 0.0038
657 TEMPERATURE INTOLERANCE 39 0.0038
658 PERIPHERAL SWELLING 579 0.0038
659 MULTIPLE SCLEROSIS RELAPSE 257 0.0037
660 PYREXIA 1296 0.0037
661 JOINT INJURY 80 0.0037
662 PSORIATIC ARTHROPATHY 152 0.0037
663 ATRIAL FIBRILLATION 364 0.0037
664 GOUT 67 0.0037
665 IRRITABLE BOWEL SYNDROME 80 0.0037
666 NEPHROLITHIASIS 171 0.0037
667 DRUG ERUPTION 66 0.0037
668 KIDNEY INFECTION 73 0.0037
669 DERMATITIS ATOPIC 196 0.0037
670 DENTAL CARIES 41 0.0037
671 COUGH 1036 0.0037
672 DYSPNOEA 2089 0.0037
673 LIMB INJURY 100 0.0037
674 PAIN IN JAW 104 0.0037
675 HYPERTENSION 777 0.0037
676 OFF LABEL USE 3203 0.0037
677 NASOPHARYNGITIS 673 0.0036
678 OEDEMA PERIPHERAL 445 0.0036
679 THERAPEUTIC RESPONSE SHORTENED 121 0.0036
680 OSTEOPOROSIS 150 0.0036
681 COVID-19 PNEUMONIA 43 0.0036
682 SCIATICA 58 0.0036
683 FEELING HOT 223 0.0036
684 HAEMOGLOBIN DECREASED 372 0.0036
685 MULTIPLE SCLEROSIS 173 0.0036
686 ANKLE FRACTURE 56 0.0036
687 ARTHRALGIA 1501 0.0036
688 HEMIPARESIS 61 0.0036
689 SPLENOMEGALY 42 0.0036
690 OROPHARYNGEAL PAIN 331 0.0036
691 OESOPHAGITIS 39 0.0036
692 ORAL CANDIDIASIS 47 0.0036
693 INJECTION SITE EXTRAVASATION 44 0.0036
694 SKIN INFECTION 40 0.0036
695 CYANOSIS 56 0.0036
696 DEVICE OCCLUSION 50 0.0035
697 PULMONARY OEDEMA 159 0.0035
698 ILLNESS 365 0.0035
699 LIVER FUNCTION TEST INCREASED 76 0.0035
700 REBOUND EFFECT 40 0.0035
701 DYSPEPSIA 348 0.0035
702 HAIR COLOUR CHANGES 44 0.0035
703 MULTIPLE ORGAN DYSFUNCTION SYNDROME 100 0.0035
704 BLOOD URINE PRESENT 67 0.0035
705 CHOLECYSTITIS 42 0.0035
706 PROTEINURIA 67 0.0035
707 PNEUMONIA 1140 0.0035
708 HEPATITIS 90 0.0035
709 WOUND 98 0.0035
710 DEVICE DISLOCATION 152 0.0035
711 PERIPHERAL COLDNESS 48 0.0035
712 BLOOD COUNT ABNORMAL 53 0.0035
713 BLOOD CREATININE INCREASED 228 0.0035
714 INTESTINAL OBSTRUCTION 130 0.0034
715 INTENTIONAL PRODUCT MISUSE 301 0.0034
716 CANDIDA INFECTION 58 0.0034
717 CHOKING 67 0.0034
718 HYPERLIPIDAEMIA 41 0.0034
719 POLYNEUROPATHY 41 0.0034
720 DRUG WITHDRAWAL SYNDROME 300 0.0034
721 CHOLELITHIASIS 112 0.0034
722 SINUS CONGESTION 46 0.0034
723 BLOOD UREA INCREASED 57 0.0034
724 DYSMENORRHOEA 45 0.0034
725 HYPERTHYROIDISM 49 0.0034
726 SINUS DISORDER 67 0.0034
727 BURNING SENSATION 237 0.0034
728 PNEUMONITIS 92 0.0034
729 BLOOD PRESSURE ABNORMAL 67 0.0034
730 MUSCULOSKELETAL DISORDER 64 0.0034
731 VISUAL IMPAIRMENT 416 0.0034
732 RENAL IMPAIRMENT 282 0.0034
733 RESPIRATORY FAILURE 244 0.0033
734 CHEST DISCOMFORT 342 0.0033
735 PSORIASIS 436 0.0033
736 INSURANCE ISSUE 51 0.0033
737 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 174 0.0033
738 FAECES DISCOLOURED 72 0.0033
739 LOWER RESPIRATORY TRACT INFECTION 151 0.0033
740 MUSCLE ATROPHY 42 0.0033
741 LOCALISED INFECTION 80 0.0033
742 VIRAL INFECTION 110 0.0033
743 PLEURAL EFFUSION 201 0.0033
744 HAIR TEXTURE ABNORMAL 44 0.0033
745 EJECTION FRACTION DECREASED 51 0.0033
746 HAEMORRHOIDS 64 0.0033
747 NASAL CONGESTION 192 0.0033
748 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 56 0.0033
749 RHINORRHOEA 211 0.0033
750 GASTROINTESTINAL HAEMORRHAGE 272 0.0033
751 TASTE DISORDER 66 0.0032
752 MUSCLE SPASMS 595 0.0032
753 COAGULOPATHY 54 0.0032
754 TRANSIENT ISCHAEMIC ATTACK 109 0.0032
755 BLOOD TRIGLYCERIDES INCREASED 57 0.0032
756 ACUTE RESPIRATORY DISTRESS SYNDROME 57 0.0032
757 SCAR 55 0.0032
758 GASTROENTERITIS VIRAL 58 0.0032
759 CORONARY ARTERY OCCLUSION 44 0.0032
760 SKIN LESION 88 0.0032
761 FEBRILE NEUTROPENIA 212 0.0032
762 SPINAL FRACTURE 64 0.0032
763 COLITIS 121 0.0032
764 EAR PAIN 62 0.0032
765 PULMONARY CONGESTION 42 0.0032
766 HERPES ZOSTER 183 0.0032
767 RASH ERYTHEMATOUS 152 0.0032
768 JOINT STIFFNESS 83 0.0032
769 LYMPHADENOPATHY 112 0.0032
770 HYPERCALCAEMIA 39 0.0032
771 RASH PRURITIC 171 0.0032
772 MUSCULOSKELETAL PAIN 165 0.0031
773 PHOTOSENSITIVITY REACTION 52 0.0031
774 NEUROPATHY PERIPHERAL 299 0.0031
775 ABDOMINAL DISTENSION 328 0.0031
776 PRODUCT DOSE OMISSION ISSUE 923 0.0031
777 PERITONITIS 65 0.0031
778 AMENORRHOEA 55 0.0031
779 HYPOACUSIS 135 0.0031
780 HIP ARTHROPLASTY 48 0.0031
781 PAIN 1924 0.0031
782 PERICARDIAL EFFUSION 72 0.0031
783 HEART RATE IRREGULAR 70 0.0031
784 PARALYSIS 44 0.0031
785 POST PROCEDURAL COMPLICATION 59 0.0031
786 PRURITUS 1178 0.0031
787 SINUSITIS 314 0.0031
788 TOOTH DISORDER 68 0.0031
789 RASH MACULO-PAPULAR 68 0.0031
790 BACTERIAL INFECTION 57 0.0031
791 SURGERY 179 0.0031
792 CEREBROVASCULAR ACCIDENT 517 0.0030
793 THYROID DISORDER 47 0.0030
794 HYPERGLYCAEMIA 111 0.0030
795 BLOOD CHOLESTEROL INCREASED 141 0.0030
796 HYPERSENSITIVITY 559 0.0030
797 THERAPEUTIC RESPONSE UNEXPECTED 135 0.0030
798 CHEST PAIN 557 0.0030
799 ABDOMINAL PAIN LOWER 76 0.0030
800 OEDEMA 163 0.0030
801 BACK PAIN 697 0.0030
802 INFECTION 434 0.0030
803 DRUG INEFFECTIVE 3940 0.0030
804 PANCREATITIS 158 0.0030
805 ACUTE MYOCARDIAL INFARCTION 88 0.0030
806 SKIN REACTION 42 0.0030
807 RASH 1296 0.0030
808 UPPER RESPIRATORY TRACT INFECTION 137 0.0030
809 FLATULENCE 168 0.0030
810 FRACTURE 56 0.0030
811 IMMUNODEFICIENCY 44 0.0029
812 NEUTROPHIL COUNT DECREASED 120 0.0029
813 UNEVALUABLE EVENT 222 0.0029
814 WHITE BLOOD CELL COUNT DECREASED 318 0.0029
815 FUNGAL INFECTION 97 0.0029
816 CARDIOMYOPATHY 43 0.0029
817 RESPIRATORY DISORDER 87 0.0029
818 THROMBOCYTOPENIA 325 0.0029
819 THERAPEUTIC PRODUCT EFFECT DECREASED 130 0.0029
820 EMOTIONAL DISTRESS 351 0.0029
821 PULMONARY ARTERIAL HYPERTENSION 42 0.0029
822 NEUTROPENIA 394 0.0029
823 PULMONARY MASS 43 0.0029
824 PROCEDURAL PAIN 80 0.0029
825 THROAT TIGHTNESS 78 0.0029
826 INFUSION RELATED REACTION 191 0.0029
827 CARDIAC FAILURE 231 0.0029
828 CELLULITIS 145 0.0029
829 HEPATIC CIRRHOSIS 54 0.0029
830 SEPTIC SHOCK 125 0.0029
831 DRY EYE 142 0.0028
832 ROAD TRAFFIC ACCIDENT 119 0.0028
833 EYE DISORDER 93 0.0028
834 ANGINA PECTORIS 81 0.0028
835 ARTHROPATHY 157 0.0028
836 HEPATIC FAILURE 85 0.0028
837 SKIN DISORDER 94 0.0028
838 THERAPEUTIC RESPONSE DECREASED 170 0.0028
839 HEPATOTOXICITY 62 0.0028
840 EPISTAXIS 208 0.0028
841 PARAESTHESIA ORAL 40 0.0028
842 CATARACT 165 0.0028
843 BASAL CELL CARCINOMA 43 0.0028
844 SKIN ULCER 71 0.0027
845 RASH MACULAR 96 0.0027
846 EAR INFECTION 73 0.0027
847 INFLUENZA LIKE ILLNESS 225 0.0027
848 FULL BLOOD COUNT DECREASED 55 0.0027
849 LOWER LIMB FRACTURE 52 0.0027
850 DRUG EFFECT LESS THAN EXPECTED 40 0.0027
851 PLATELET COUNT DECREASED 287 0.0027
852 NERVOUS SYSTEM DISORDER 84 0.0027
853 CARDIOVASCULAR DISORDER 68 0.0027
854 CONVULSION 153 0.0027
855 DRUG RESISTANCE 68 0.0026
856 RESPIRATORY TRACT CONGESTION 42 0.0026
857 DEAFNESS 69 0.0026
858 BLISTER 148 0.0026
859 ACTIVITIES OF DAILY LIVING IMPAIRED 52 0.0026
860 GASTRIC DISORDER 90 0.0026
861 ALOPECIA 515 0.0026
862 INFLAMMATION 135 0.0026
863 HEPATIC ENZYME INCREASED 178 0.0026
864 AGEUSIA 65 0.0026
865 TYPE 2 DIABETES MELLITUS 87 0.0026
866 BONE DISORDER 47 0.0026
867 PRODUCT DISPENSING ERROR 56 0.0026
868 JOINT SWELLING 310 0.0026
869 MUCOSAL INFLAMMATION 67 0.0026
870 IMPAIRED HEALING 84 0.0026
871 PRODUCT USE ISSUE 479 0.0025
872 COMPLICATION OF DEVICE REMOVAL 46 0.0025
873 PULMONARY HYPERTENSION 53 0.0025
874 SWELLING 238 0.0025
875 CEREBRAL INFARCTION 62 0.0025
876 BACK DISORDER 41 0.0025
877 ABORTION SPONTANEOUS 101 0.0025
878 BONE PAIN 147 0.0025
879 SNEEZING 55 0.0024
880 THROAT IRRITATION 110 0.0024
881 ILL-DEFINED DISORDER 148 0.0024
882 PRODUCT PRESCRIBING ISSUE 53 0.0024
883 DIABETES MELLITUS 185 0.0024
884 ANAPHYLACTIC REACTION 134 0.0024
885 FLUSHING 245 0.0024
886 HOSPITALISATION 370 0.0024
887 STAPHYLOCOCCAL INFECTION 79 0.0024
888 SKIN EXFOLIATION 202 0.0024
889 KNEE ARTHROPLASTY 50 0.0024
890 DRUG EFFECT INCOMPLETE 86 0.0024
891 EYE SWELLING 88 0.0024
892 FLUID RETENTION 119 0.0023
893 OSTEOMYELITIS 42 0.0023
894 DIABETES MELLITUS INADEQUATE CONTROL 41 0.0023
895 RHEUMATOID ARTHRITIS 262 0.0023
896 LIVER FUNCTION TEST ABNORMAL 67 0.0023
897 RENAL DISORDER 107 0.0023
898 INTENTIONAL DRUG MISUSE 48 0.0023
899 INTERSTITIAL LUNG DISEASE 111 0.0023
900 DERMATITIS 48 0.0023
901 PRODUCT PHYSICAL ISSUE 46 0.0023
902 STEVENS-JOHNSON SYNDROME 50 0.0022
903 ORAL PAIN 50 0.0022
904 LIVER DISORDER 99 0.0022
905 SKIN CANCER 48 0.0022
906 FEMUR FRACTURE 69 0.0022
907 TOOTH LOSS 46 0.0022
908 SYNOVITIS 40 0.0022
909 CHROMATURIA 50 0.0022
910 CONTRAINDICATED PRODUCT ADMINISTERED 67 0.0022
911 DIABETIC KETOACIDOSIS 53 0.0022
912 SKIN DISCOLOURATION 101 0.0022
913 RENAL FAILURE ACUTE 93 0.0022
914 URTICARIA 367 0.0022
915 MENORRHAGIA 43 0.0022
916 CONJUNCTIVITIS 40 0.0022
917 PELVIC PAIN 39 0.0021
918 HAEMORRHAGE 223 0.0021
919 DISABILITY 42 0.0021
920 ERUCTATION 41 0.0021
921 LACRIMATION INCREASED 64 0.0021
922 CORONARY ARTERY DISEASE 64 0.0021
923 ERYTHEMA 427 0.0021
924 UNDERDOSE 151 0.0021
925 DISEASE PROGRESSION 244 0.0021
926 STOMATITIS 125 0.0021
927 DRY SKIN 275 0.0021
928 CYTOKINE RELEASE SYNDROME 41 0.0020
929 PAIN OF SKIN 55 0.0020
930 DRUG PRESCRIBING ERROR 39 0.0020
931 VAGINAL HAEMORRHAGE 88 0.0020
932 LIP SWELLING 66 0.0020
933 CARDIAC DISORDER 184 0.0020
934 INJECTION SITE REACTION 134 0.0019
935 RASH PAPULAR 43 0.0019
936 PRURITUS GENERALISED 41 0.0019
937 INJECTION SITE MASS 70 0.0019
938 BONE DENSITY DECREASED 58 0.0018
939 INJECTION SITE PRURITUS 124 0.0018
940 INCORRECT PRODUCT ADMINISTRATION DURATION 40 0.0018
941 DEVICE MALFUNCTION 129 0.0018
942 EYE PRURITUS 61 0.0018
943 CARDIAC FAILURE CONGESTIVE 145 0.0018
944 HEPATIC FUNCTION ABNORMAL 67 0.0018
945 DRUG EXPOSURE DURING PREGNANCY 61 0.0018
946 VISUAL ACUITY REDUCED 59 0.0018
947 PLASMA CELL MYELOMA 69 0.0018
948 ANAPHYLACTIC SHOCK 45 0.0017
949 DRUG DEPENDENCE 279 0.0017
950 NEOPLASM PROGRESSION 60 0.0017
951 DEATH 1466 0.0017
952 MALIGNANT NEOPLASM PROGRESSION 173 0.0017
953 EXPIRED PRODUCT ADMINISTERED 56 0.0017
954 NEEDLE ISSUE 49 0.0017
955 BLOOD GLUCOSE DECREASED 80 0.0017
956 EXTRA DOSE ADMINISTERED 67 0.0017
957 DEVICE ISSUE 146 0.0016
958 DEVICE BREAKAGE 66 0.0016
959 DRUG DOSE OMISSION 267 0.0016
960 GLYCOSYLATED HAEMOGLOBIN INCREASED 40 0.0016
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 320 0.0016
962 INCORRECT DOSE ADMINISTERED 357 0.0016
963 ADVERSE EVENT 144 0.0016
964 GYNAECOMASTIA 48 0.0015
965 RASH GENERALISED 40 0.0015
966 DRUG EFFECT DECREASED 83 0.0015
967 PRODUCT QUALITY ISSUE 204 0.0015
968 MYOCARDIAL INFARCTION 261 0.0015
969 INJURY 105 0.0015
970 EYE IRRITATION 85 0.0015
971 DRUG ADMINISTRATION ERROR 45 0.0015
972 BLOOD GLUCOSE INCREASED 275 0.0015
973 LABORATORY TEST ABNORMAL 40 0.0014
974 ACNE 101 0.0013
975 OCULAR HYPERAEMIA 63 0.0013
976 NEOPLASM MALIGNANT 85 0.0013
977 INJECTION SITE SWELLING 97 0.0013
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 88 0.0012
979 INJECTION SITE ERYTHEMA 152 0.0012
980 SKIN IRRITATION 56 0.0012
981 INJECTION SITE PAIN 364 0.0012
982 INJECTION SITE BRUISING 94 0.0012
983 BREAST CANCER 108 0.0012
984 SKIN BURNING SENSATION 81 0.0011
985 DEVICE LEAKAGE 43 0.0010
986 NO ADVERSE EVENT 175 0.0010
987 ACCIDENTAL EXPOSURE TO PRODUCT 97 0.0009
988 INJECTION SITE HAEMORRHAGE 65 0.0008
989 DEVICE EXPULSION 46 0.0007
990 PROSTATE CANCER 46 0.0006
991 DRUG DOSE OMISSION BY DEVICE 43 0.0005
992 PRODUCT STORAGE ERROR 41 0.0005